This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
New Data, Case Studies & Partners
September 4th-5th, 2024San Diego Convention Center, USA

Daniel Fischer
CEO at Tevard Biosciences


Daniel Fischer is co-founder and CEO of Tevard Biosciences, a company pioneering tRNA therapeutics to treat rare genetic diseases, including Dravet syndrome, a disease that affects his daughter Natasha. He brings extensive management and entrepreneurial expertise and has been a management consultant to Fortune 500 companies with several top-tier consultancies, including A.T. Kearney and Arthur D. Little.

Daniel worked at the Massachusetts Institute of Technology with industry and academic researchers in advancing the state-of-the-art in multiple disciplines, including AI/machine learning, biotechnology, and innovation management. Daniel is a 2022 Termeer Fellow, and lives in Newton, MA with his wife Karina and 4 children: Jonathan, David, Nicole and Natasha.

At this event